Semi-Supervised Active Learning for COVID-19 Lung Ultrasound
  Multi-symptom Classification
  Ultrasound (US) is a non-invasive yet effective medical diagnostic imaging
technique for the COVID-19 global pandemic. However, due to complex feature
behaviors and expensive annotations of US images, it is difficult to apply
Artificial Intelligence (AI) assisting approaches for lung's multi-symptom
(multi-label) classification. To overcome these difficulties, we propose a
novel semi-supervised Two-Stream Active Learning (TSAL) method to model
complicated features and reduce labeling costs in an iterative procedure. The
core component of TSAL is the multi-label learning mechanism, in which label
correlations information is used to design multi-label margin (MLM) strategy
and confidence validation for automatically selecting informative samples and
confident labels. On this basis, a multi-symptom multi-label (MSML)
classification network is proposed to learn discriminative features of lung
symptoms, and a human-machine interaction is exploited to confirm the final
annotations that are used to fine-tune MSML with progressively labeled data.
Moreover, a novel lung US dataset named COVID19-LUSMS is built, currently
containing 71 clinical patients with 6,836 images sampled from 678 videos.
Experimental evaluations show that TSAL using only 20% data can achieve
superior performance to the baseline and the state-of-the-art. Qualitatively,
visualization of both attention map and sample distribution confirms the good
consistency with the clinic knowledge.
